英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
Enucleating查看　Enucleating　在百度字典中的解释百度英翻中〔查看〕
Enucleating查看　Enucleating　在Google字典中的解释Google英翻中〔查看〕
Enucleating查看　Enucleating　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Libtayo, INN-cemiplimab - European Medicines Agency
    LIBTAYO as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy
  • LIBTAYO 350 mg concentrate for solution for infusion
    LIBTAYO 350 mg concentrate for solution for infusion - Summary of Product Characteristics (SmPC) by Regeneron UK Limited
  • LIBTAYO® Full Prescribing Information | Regeneron
    LIBTAYO is a clear to slightly opalescent, colorless to pale yellow solution that may contain trace amounts of translucent to white particles Discard the vial if the solution is cloudy, discolored or contains extraneous particulate matter other than trace amounts of translucent to white particles
  • PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION LIBTAYOTM
    Cervical Cancer LIBTAYO (cemiplimab for injection) is indicated for: • the treatment of adult patients with cervical cancer who have progressed on or after prior platinum-based chemotherapy and who require additional systemic therapy to treat recurrent or metastatic disease
  • LIBTAYO (cemiplimab-rwlc) Label - Food and Drug Administration
    LIBTAYO (cemiplimab-rwlc) injection for intravenous use is a sterile, clear to slightly opalescent, colorless to pale yellow solution with a pH of 6 The solution may contain trace amounts of translucent to white particles
  • Libtayo, INN-cemiplimab - BJMO
    LIBTAYO is for intravenous use It is administered by intravenous infusion over 30 minutes through an intravenous line containing a sterile, non-pyrogenic, low-protein binding, in-line or add-on filter (0 2 micron to 5 micron pore size)
  • LIBTAYO Full Prescribing Information
    LIBTAYO is a monoclonal antibody that belongs to a class of drugs that bind to either the programmed death receptor-1 (PD-1) or PD-ligand 1 (PD-L1), blocking the PD-1 PD-L1 pathway, thereby removing inhibition of the immune response, potentially breaking peripheral tolerance and inducing immune-mediated adverse reactions
  • Libtayo - European Medicines Agency (EMA)
    Libtayo is a cancer medicine used in adults to treat: a type of skin cancer called cutaneous squamous cell carcinoma when the cancer is locally advanced (has spread nearby) or metastatic (has spread to other parts of the body)
  • Libtayo (cemiplimab-rwlc) - OHSU
    Libtayo [package insert] Tarrytown, NY; Regeneron Pharmace ticals, Inc ; April 20 ndium®) cemiplimab-rwlc National Comprehen ive Cancer Network, 2025 The NCCN Compendium® is a derivative work of the NCCN Guidelines® NATIONAL COMPREHENSIVE CANCER NETWORK®, NCCN®, and NCCN GUIDELINES® are trademarks owned by the National Comprehe
  • label - Food and Drug Administration
    Permanently discontinue LIBTAYO for life-threatening (Grade 4) immune-mediated adverse reactions, recurrent severe (Grade 3) immune-mediated reactions that require systemic immunosuppressive treatment, or an inability to reduce corticosteroid dose to 10 mg or less of prednisone equivalent per day within 12 weeks of initiating steroids





中文字典-英文字典  2005-2009